Healthcare & Life Sciences
Diasome Pharmaceuticals
United Statesdiasome.com/
Diasome Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Diasome Pharmaceuticals
Diasome Pharmaceuticals is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Diasome Pharmaceuticals develops liver-targeted insulin and metabolic therapies that deliver drugs directly to the portal-hepatic region to improve glycemic control and reduce hypoglycemia risk in diabetes patients.
Explore Diasome Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.